AIM VACCINE (06660)
AIM Vaccine Co., Ltd. engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China and int...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 1.835
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- -33.33%
- Amplitude
- --
- 52wk High
- 5.330
- Volume Ratio
- 0.00
- Turnover Ratio
- --
AIM VACCINE Analyst Rating
View moreForecast & Rating
Aug 29, 2025Price forecast
HK$10.96502.15%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 2 days ago, 11:33 AM
Hong Kong Equities Navigate Cross-Border Headwinds as Tech and Biotech Diverge in 2026
- Tip Ranks · Aug 24 at 12:14 AM
AIM Vaccine Seeks Approval for High-Potency Human Diploid Cell Rabies Shot
- PUBT · Aug 24 at 12:02 AM
AIM Vaccine files NMPA registration for high-potency human diploid rabies vaccine
- Tip Ranks · Aug 23 at 11:07 AM
AIM Vaccine Interim Revenue Slides as Losses Narrow Slightly
- Tip Ranks · Aug 3 at 12:09 AM
AIM Vaccine Advances Serum-Free Rabies Shot Toward China Market Approval
- PUBT · Aug 3 at 12:00 AM
AIM Vaccine submits additional NMPA data for serum-free rabies vaccine after Phase III trial unblinding
